Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: McNeil Products Limited, Foundation Park, Roxborough Way, Maidenhead, Berkshire SL6 3UG, United Kingdom
This product is indicated for the symptomatic relief of nasal congestion associated with the common cold, influenza, sinusitis, allergic and non-allergic rhinitis, and other upper respiratory tract allergies.
One spray to be expressed into each nostril 2-3 times daily, as necessary.
Maximum daily dose: 3 sprays in 24 hours.
Use for more than seven consecutive days is not recommended, [See section 4.4].
Do not give to children under 12 years of age.
Experience has indicated that normal adult dosage is appropriate, [See section 5.2].
Normal adult dosage is appropriate, [See section 5.2].
Nasal.
Systemic action is unlikely when applied nasally due to the local vasoconstriction that inhibits absorption. If systemic absorption does occur xylometazoline as an α2-adrenergic agonist could be expected to produce effects similar to those of clonidine with a short lived rise in blood pressure, followed by more prolonged hypotension and sedation.
Treatment of overdose should be supportive.
3 years.
Do not store above 25°C.
Amber glass bottle of either 10 ml or 15 ml nominal fill volume.
The bottle is sealed with an integral snap-on metered 0.14 ml pump consisting of a white plastic actuator and natural polyethylene pull-off overcap.
No special requirements.
Any unused product or waste material should be disposed of in accordance with local requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
